Nicholson Ryan sold $84K of DLB

Nicholson Ryan (VP, CAO and Corp. Controller) sold 1,348 shares of Dolby Laboratories, Inc. (DLB) at $62.04 on 2026-08-10.

Original reporting
SEC EDGAR · Nicholson Ryan
Published Aug 12, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 12, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$DLB
Neutral
medium confidence
Mentioned
$DLB
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DLBNeutralLow
01

Why it matters

The disclosure updates the record of insider activity and may influence short-term sentiment, but it does not provide new company fundamentals or forward-looking guidance.

02

Market read

Traders may note the insider sale for sentiment monitoring, but the filing alone is unlikely to drive a sustained repricing without additional fundamental news.

03

What to watch

The article does not state whether other insiders bought/sold, whether the sale was part of a broader pattern, or whether the insider’s compensation/vesting schedule explains the transaction.

Relevance 3/10Novelty 3/10Timing: Form 4 filed 2026-08-12 after-hours; sale dated 2026-08-10.

Background

This is an SEC Form 4 insider transaction disclosure for Dolby Laboratories, Inc.

Company-level read

Ticker impact

$DLBNeutralMedium confidence
Context

Dolby Laboratories insider Nicholson Ryan sold 1,348 shares at $62.04 on 2026-08-10, per a Form 4 filed 2026-08-12.

Expected impact

Likely limited, short-lived sentiment impact; no clear directional signal beyond typical insider-selling noise.

Evidence & confidence

The filing is a primary-source Form 4, but the article provides only a single sale size and price, with no accompanying guidance, operational change, or buyback/financing event.

Market effects

Minimal. Insider selling in a single media/tech hardware name typically does not reset sector expectations.

None indicated.

None indicated.

Counterpoint

The absence of a disclosed 10b5-1 plan could be interpreted as discretionary selling, but insider sales are often driven by diversification or tax planning rather than bearish fundamentals.

Key entities

  • Dolby Laboratories, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Nicholson Ryan

    VP, CAO and Corp. Controller who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NVDAMedAI 8/10

Futures Rise As Huang-less Nvidia Beats And Raises, Gold Crashes Below $3,800

US futures rise as Nvidia (NVDA) reports strong earnings and raises guidance, boosting AI-related stocks. Gold drops below $3,800 after Fed Governor Waller's comments. Nvidia's Q4 revenue guidance is $130B vs. estimates of $125B. Premarket movers include TSLA, GOOGL, AMZN, AAPL, META, AVGO, CRWV, AAOI, BLSH, DLB, LOW, SLS, TTWO, TNDM. Fed policy and economic data releases are in focus.

$DLBMed

Dolby Laboratories Q4 Earnings Call Highlights

Dolby Laboratories reported Q4 earnings with Atmos, Vision, and imaging patents revenue growing 18%, surpassing foundational audio. The company expects mid-single-digit declines in foundational audio and similar growth in other segments for fiscal 2027. New CEO Kevin Whitten focuses on AI and recurring revenue. Dolby anticipates Q1 revenue of $285M-$305M and full-year non-GAAP operating expenses of $775M. The company has $713M in cash and no debt, repurchasing $265M in shares in fiscal 2026.

$DLBMedAI 9/10

Dolby Laboratories Profit Advances In Q4

Dolby Laboratories (DLB) reported Q4 earnings of $80.9M ($0.86 per share), up from $49.3M ($0.51 per share) last year. Adjusted earnings were $117.8M ($1.25 per share). Revenue increased 21.7% to $373.5M. The company guided next quarter's EPS to $0.41-$0.56 and revenue to $285M-$305M.